Trials / Completed
CompletedNCT00955851
A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- George Washington University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigators in the Division of Infectious Diseases and the Division of Hospital Medicine of The George Washington University Medical Center are carrying out a study to determine if hospitalized patients receiving the polyvalent pneumococcal vaccine during an acute illness develop an adequate antibody response. The study group will consist of individuals diagnosed with pneumonia and admitted to the Medicine ward under the Pneumonia Core Measure Protocol, which assigns appropriate patients for vaccination based on the current guidelines from the Advisory Committee on Immunization Practices (ACIP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pre and post vaccination titers | Titers will be obtained pre vaccination and 4 weeks post vaccination |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2009-08-10
- Last updated
- 2010-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00955851. Inclusion in this directory is not an endorsement.